Focus: Arsenal Biosciences is a public biotech company headquartered in South San Francisco focused on oncology and cancer treatments. The company operates a clinical-stage pipeline with early-phase programs in solid tumors and also maintains assets in emergency medicine.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Recent layoff filing — 100 affected
Source: state DOL filings via Big Local News
Arsenal presents early-stage oncology opportunity but elevated restructuring risk; suitable for scientists seeking R&D impact but unsuitable for those prioritizing stability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Arsenal Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Arsenal Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Source: state DOL filings, aggregated via Big Local News
Recent layoff WARN filing is a material red flag; timing and scope suggest ongoing organizational stress and heightened employment instability.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo